| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |